DexCom
DXCM
84.30
+0.91
+1.09%
DexCom
US · DXCM
#635 by market cap
Listed 2005
84.30
+0.91
+1.09%
Live - 5344 symbols - heartbeat 29s ago
· 2026-10-08 04:00
Pre-market
84.24
-0.07%
After-hours
84.30
0.00%
Overnight
84.24
-0.07%
- Market cap
- 31.81B
- P/E (TTM)i
- 33.32
- P/Bi
- 12.13
- EPSi
- 2.09
- Div yieldi
- 0.00%
- 52W posi
- 78%
Reader sentiment
Are you bullish or bearish on DXCM?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 19 analysts
Buy
Avg price target
93.76 +11.2%
Price target rangecurrent 84.30
Low82.00
Avg93.76
High105.00
Buy 95%
Hold 5%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-29 | Wells Fargo | -- | BUY | 90.00 |
| 2026-09-23 | Truist Financial | -- | BUY | 102.00 |
| 2026-09-18 | TD Cowen | -- | BUY | 95.00 |
| 2026-09-18 | Truist Financial | -- | BUY | 102.00 |
| 2026-09-09 | Wells Fargo | -- | BUY | 90.00 |
| 2026-08-14 | Citi | -- | BUY | 105.00 |
| 2026-08-13 | Citi | -- | BUY | 105.00 |
| 2026-08-04 | Mizuho Securities | -- | BUY | 95.00 |
| 2026-08-03 | CCORF | -- | BUY | 90.00 |
| 2026-08-03 | Argus Research | -- | BUY | 96.00 |
| 2026-07-31 | Wells Fargo | -- | BUY | 90.00 |
| 2026-07-31 | William Blair | -- | BUY | -- |
| 2026-07-31 | StoneX | -- | BUY | 82.00 |
| 2026-07-31 | Mizuho Securities | -- | BUY | 95.00 |
| 2026-07-31 | Piper Sandler | -- | BUY | 95.00 |
| 2026-07-31 | Raymond James | -- | BUY | 94.00 |
| 2026-07-31 | BTIG | -- | BUY | 90.00 |
| 2026-07-31 | BofA Securities | -- | BUY | -- |
| 2026-07-31 | Truist Financial | -- | BUY | 93.00 |
| 2026-07-31 | Baird | -- | BUY | 105.00 |
| 2026-07-31 | Deutsche Bank | -- | BUY | 92.00 |
| 2026-07-31 | Stifel | -- | BUY | 95.00 |
| 2026-07-31 | Citi | -- | BUY | 88.00 |
| 2026-07-31 | RBC Capital | -- | BUY | 90.00 |
| 2026-07-31 | J.P. Morgan | -- | HOLD | 82.00 |
Quant vs Street three independent views, side by side
StockVane factor grade
A+
Momentum strategy signal
Hold
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Mixed
1
■ Upgrades■ Downgrades
- 1 upgrade vs 0 downgrades among tracked analyst rating changes.
- Most recent: Morgan Stanley moved from Hold to Buy on 2025-12-02.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2025-12-02 | Morgan Stanley | HOLD → BUY | 75.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-07-30 | After close | ±9.48% | +11.95% (beat) |
| 2026/Q1 | 2026-04-30 | After close | ±10.79% | +3.02% (in line) |
| 2025/Q4 | 2026-02-12 | After close | ±11.60% | +7.59% (in line) |
| 2025/Q3 | 2025-10-30 | After close | ±16.01% | -14.63% (in line) |
| 2025/Q2 | 2025-07-30 | After close | ±9.84% | -9.31% (in line) |
| 2025/Q1 | 2025-05-01 | After close | ±11.62% | +16.17% (beat) |
| 2024/Q4 | 2025-02-13 | After close | ±10.25% | +5.92% (in line) |
| 2024/Q3 | 2024-10-24 | After close | ±13.48% | -1.88% (in line) |
| 2024/Q2 | 2024-07-25 | After close | ±12.10% | -40.66% (beat) |
| 2023/Q4 | 2024-02-08 | After close | ±8.30% | -5.18% (in line) |
| 2023/Q3 | 2023-10-26 | After close | ±14.75% | +10.11% (in line) |
| 2023/Q2 | 2023-07-27 | After close | ±9.60% | +2.33% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 04:00:02 · For reference only, not investment advice and not tailored to your situation.